The Workforce Pell Grant program, which goes into effect on July 1, expands the popular grants for low-income undergraduates into new territory, opening up eligibility to programs under 15 weeks. It’s ...
A Florida woman was sentenced to 22 months in prison for running a massive years-long scheme to traffic thousands of stolen Microsoft Certificate of Authenticity (COA) labels.
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Automatic Data Processing, Inc. (NASDAQ:ADP) Q3 2025 Earnings Call Transcript April 30, 2025 Automatic Data Processing, Inc. beats earnings expectations. Reported EPS is $3.06, expectations were $2.97 ...
Access to high school computer science courses has plateaued, and overall high school student participation in those classes has declined slightly, concludes Code.org’s annual report on the state of ...
But if you have HCM, you can make a number of lifestyle choices to protect your heart health and enjoy a high quality of life. Heavy lifting is potentially risky when you’re living with HCM, because ...
MINNEAPOLIS — Readouts of data on an experimental drug for hypertrophic cardiomyopathies showed the agent appeared safe and effective in long-term treatment and can significantly improve exercise ...
Stamford, CT, Sept. 19, 2025 (GLOBE NEWSWIRE) -- HCM III Acquisition Corp. (NASDAQ: HCMAU) (the “Company”) announced today that, commencing September 22, 2025, holders of the units sold in the Company ...
Oracle yesterday announced more than a dozen AI agents that will be available as part of its Fusion HCM application, complementing the twelve already announced earlier this year, along with many ...
Oracle Corp. today announced a series of new agentic artificial intelligence extensions to its Fusion Cloud Human Capital Management suite, bringing the number of agents in the application to more ...
MADRID, Spain—For patients with hypertrophic cardiomyopathy (HCM), research presented today at the European Society of Cardiology (ESC) Congress 2025 demonstrated both the promise and the potential ...
Mavacamten is approved to treat adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM). However, its effects in nonobstructive HCM remain uncertain. We conducted a phase 3, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results